• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Characterisation of Proendothelin-1 Derived Peptides and Evaluation of Their Utility as Biomarkers of Vascular and Renal Pathologies 
    •   QMRO Home
    • Queen Mary University of London Theses
    • Theses
    • Characterisation of Proendothelin-1 Derived Peptides and Evaluation of Their Utility as Biomarkers of Vascular and Renal Pathologies
    •   QMRO Home
    • Queen Mary University of London Theses
    • Theses
    • Characterisation of Proendothelin-1 Derived Peptides and Evaluation of Their Utility as Biomarkers of Vascular and Renal Pathologies
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Characterisation of Proendothelin-1 Derived Peptides and Evaluation of Their Utility as Biomarkers of Vascular and Renal Pathologies

    View/Open
    J Yuzugulen UoL PhD.pdf (4.071Mb)
    Publisher
    Queen Mary University of London
    Metadata
    Show full item record
    Abstract
    Endothelin-1 (ET-1), the potent vasoconstrictor peptide, is synthesised from the 212 amino acid precursor preproendothelin-1 (ppET-1). ET-1 is strongly implicated in cardiac and renal pathologies. However, ET receptor antagonists demonstrated only limited efficacy in clinical trials of chronic heart failure (HF) and hypertension. ET-1 has a short circulating half-life and its plasma measurements have been inaccurate. Thus, alternative ppET-1 derived peptides may be more stable and could serve as better biomarkers of ET-1 synthesis. Moreover, alternative ppET-1 derived peptides may contribute to the biological effects resulting from EDN1 gene expression and may be interacting with the vasoconstrictor responses of ET-1 or other mediators. The aims of these investigations were to characterise ppET-1 derived peptide products and to evaluate their potential as biomarkers of ET-1 synthesis. A combination of specific immunoassays and HPLC were used to characterise ppET-1 processing in human endothelial (EA.hy 926) and epithelial (A549) cells in culture. NT-proET-1 (ppET-1[18 – 50]), endothelin-like domain peptide (ELDP, ppET-1[93 – 166]) and CT-proET-1 (ppET-1[169 – 212]) were identified in conditioned media samples as the main ppET-1 derived peptide products. The identities of ELDP and CT-proET-1 were confirmed by LC-MS/MS mass spectrometry. The three ppET-1 peptides were chemically synthesised and their in vivo clearance was investigated in male Wistar rats. Arterial plasma levels after intravenous administration of proET-1 peptides showed rapid clearance (<5 min) of NT-proET-1, while CT-proET-1 had the slowest clearance rate. Studies of proET-1 peptide stability in blood samples also showed NT-proET-1 had lower stability. Specific double-recognition site sandwich ELISAs optimised for plasma measurements were used to evaluate plasma concentrations of ELDP and CT-proET-1 in patients with chronic HF and chronic kidney disease (CKD). In conclusion, the results described in this thesis provide further evidence linking ET-1 to cardiac and renal disease processes. But the small differences between healthy individuals and patients with cardiovascular or renal disease indicate only a limited potential for proET-1 peptides as diagnostic biomarkers of EDN1-linked pathologies.
    Authors
    Yuzugulen, Jale
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/8388
    Collections
    • Theses [3321]
    Copyright statements
    The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the author
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.